PH-Interacting Protein (PHIP) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-PH-Interacting Protein (PHIP) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPH-Interacting Protein (PHIP)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatfluorescein (FITC) conjugate
Size20 µg, 50 µg, 100 µg, 200 µg+
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionPHIP antibody (FITC) is a Rabbit polyclonal against PHIP conjugated to FITC.
ImmunogenRecombinant Human PH-interacting protein (508-608AA).
Other Namesndrp, BRWD2, WDR11, DCAF14, PH-interacting proteinPHIP, IRS-1 PH domain-binding protein, WD repeat-containing protein 11, PHIP, ndrp, ndrp, ndrp , ndrp , BRWD2, BRWD2, BRWD2 , BRWD2 , WDR11, WDR11, WDR11 , WDR11 , DCAF14, DCAF14, DCAF14 , DCAF14 , PH-interacting proteinPHIP, PH-interacting proteinPHIP, PH-interacting proteinPHIP , PH-interacting proteinPHIP , IRS-1 PH domain-binding protein, IRS-1 PH domain-binding protein, IRS-1 PH domain-binding protein , IRS-1 PH domain-binding protein , WD repeat-containing protein 11, WD repeat-containing protein 11, WD repeat-containing protein 11 , WD repeat-containing protein 11 , PHIP, PHIP, PHIP , PHIP
Gene, Accession #PHIP, Gene ID: 55023, UniProt: Q8WWQ0
Catalog #abx315093
Priceplease inquire
Order / More InfoPH-Interacting Protein (PHIP) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.